Home/Filings/4/0001879785-21-000038
4//SEC Filing

Harrell James Archie Jr 4

Accession 0001879785-21-000038

CIK 0001534120other

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 5:16 PM ET

Size

4.6 KB

Accession

0001879785-21-000038

Insider Transaction Report

Form 4
Period: 2021-12-10
Harrell James Archie Jr
Exec. VP, Mktg & External Comm
Transactions
  • Purchase

    Common Stock

    2021-12-10$1.57/sh+1,093$1,71636,766 total
Footnotes (1)
  • [F1]These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1
  • filerCIK 0001738462

Filing Metadata

Form type
4
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 5:16 PM ET
Size
4.6 KB